← FormularyRx · Available at launch

Lipotropic Compound

Lipo-C

Lipid metabolism, weight support

Status
Available at launch

Mechanism

Lipo-C is a compounded lipotropic injection combining MIC (methionine, inositol, choline) with L-carnitine and cyanocobalamin (B12). Each component supports a different node of lipid metabolism: methionine initiates fat mobilization, inositol supports insulin signaling, choline aids phosphatidylcholine synthesis, and carnitine transports long-chain fatty acids into the mitochondrial matrix for beta-oxidation.

Indications

Adjunct to weight-loss protocols including GLP-1
Hepatic fat mobilization
Energy metabolism support
Fatty acid oxidation

Regulatory status

Compounded Lipo-C is prepared by 503A pharmacies using eligible bulk substances. Not FDA-approved as a combined formulation.

References

01Bhagavan NV, Ha CE. Essentials of Medical Biochemistry. 2015.
02FDA 503A Bulk Drug Substances List — eligible components.

This fact sheet is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved. Prescribing decisions are made by a licensed clinician based on individual medical necessity. Not all patients qualify.